The global Biologics market size was valued at USD 107170 million in 2023 and is forecast to a readjusted size of USD 150730 million by 2030 with a CAGR of 5.0% during review period.
A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA.
North America dominated with respect to revenue generation owing to the presence of significant established participants in this region. Moreover, higher demand for the products for treatment of diseases is attributive for larger revenue share.
The report includes an overview of the development of the Biologics industry chain, the market status of Infectious Diseases (Monoclonal Antibodies, Vaccines), Oncology (Monoclonal Antibodies, Vaccines), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Biologics.
Regionally, the report analyzes the Biologics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Biologics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Biologics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Biologics industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K MT), revenue generated, and market share of different by Type (e.g., Monoclonal Antibodies, Vaccines).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Biologics market.
Regional Analysis: The report involves examining the Biologics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Biologics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Biologics:
Company Analysis: Report covers individual Biologics manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Biologics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Infectious Diseases, Oncology).
Technology Analysis: Report covers specific technologies relevant to Biologics. It assesses the current state, advancements, and potential future developments in Biologics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Biologics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Biologics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
麻豆原创 segment by Type
Monoclonal Antibodies
Vaccines
Recombinant Proteins
Antisense
RNAi
麻豆原创 segment by Application
Infectious Diseases
Oncology
Immunology
Autoimmune Diseases
Major players covered
Eli Lilly & Company
Samsung Biologics
F Hoffman La Roche
Celltrion
Addgene
Amgen
Abbvie Inc.
Sanofi
Pfizer Inc.
Merck & Co. Inc.
Novo Nordisk A/S
Johnson & Johnson Services Inc.
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biologics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Biologics, with price, sales, revenue and global market share of Biologics from 2019 to 2024.
Chapter 3, the Biologics competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biologics breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Biologics market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Biologics.
Chapter 14 and 15, to describe Biologics sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope of Biologics
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Biologics Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Monoclonal Antibodies
1.3.3 Vaccines
1.3.4 Recombinant Proteins
1.3.5 Antisense
1.3.6 RNAi
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Biologics Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Infectious Diseases
1.4.3 Oncology
1.4.4 Immunology
1.4.5 Autoimmune Diseases
1.5 Global Biologics 麻豆原创 Size & Forecast
1.5.1 Global Biologics Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Biologics Sales Quantity (2019-2030)
1.5.3 Global Biologics Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Eli Lilly & Company
2.1.1 Eli Lilly & Company Details
2.1.2 Eli Lilly & Company Major Business
2.1.3 Eli Lilly & Company Biologics Product and Services
2.1.4 Eli Lilly & Company Biologics Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Eli Lilly & Company Recent Developments/Updates
2.2 Samsung Biologics
2.2.1 Samsung Biologics Details
2.2.2 Samsung Biologics Major Business
2.2.3 Samsung Biologics Biologics Product and Services
2.2.4 Samsung Biologics Biologics Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Samsung Biologics Recent Developments/Updates
2.3 F Hoffman La Roche
2.3.1 F Hoffman La Roche Details
2.3.2 F Hoffman La Roche Major Business
2.3.3 F Hoffman La Roche Biologics Product and Services
2.3.4 F Hoffman La Roche Biologics Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 F Hoffman La Roche Recent Developments/Updates
2.4 Celltrion
2.4.1 Celltrion Details
2.4.2 Celltrion Major Business
2.4.3 Celltrion Biologics Product and Services
2.4.4 Celltrion Biologics Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Celltrion Recent Developments/Updates
2.5 Addgene
2.5.1 Addgene Details
2.5.2 Addgene Major Business
2.5.3 Addgene Biologics Product and Services
2.5.4 Addgene Biologics Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Addgene Recent Developments/Updates
2.6 Amgen
2.6.1 Amgen Details
2.6.2 Amgen Major Business
2.6.3 Amgen Biologics Product and Services
2.6.4 Amgen Biologics Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Amgen Recent Developments/Updates
2.7 Abbvie Inc.
2.7.1 Abbvie Inc. Details
2.7.2 Abbvie Inc. Major Business
2.7.3 Abbvie Inc. Biologics Product and Services
2.7.4 Abbvie Inc. Biologics Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Abbvie Inc. Recent Developments/Updates
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Biologics Product and Services
2.8.4 Sanofi Biologics Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Sanofi Recent Developments/Updates
2.9 Pfizer Inc.
2.9.1 Pfizer Inc. Details
2.9.2 Pfizer Inc. Major Business
2.9.3 Pfizer Inc. Biologics Product and Services
2.9.4 Pfizer Inc. Biologics Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Pfizer Inc. Recent Developments/Updates
2.10 Merck & Co. Inc.
2.10.1 Merck & Co. Inc. Details
2.10.2 Merck & Co. Inc. Major Business
2.10.3 Merck & Co. Inc. Biologics Product and Services
2.10.4 Merck & Co. Inc. Biologics Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Merck & Co. Inc. Recent Developments/Updates
2.11 Novo Nordisk A/S
2.11.1 Novo Nordisk A/S Details
2.11.2 Novo Nordisk A/S Major Business
2.11.3 Novo Nordisk A/S Biologics Product and Services
2.11.4 Novo Nordisk A/S Biologics Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 Novo Nordisk A/S Recent Developments/Updates
2.12 Johnson & Johnson Services Inc.
2.12.1 Johnson & Johnson Services Inc. Details
2.12.2 Johnson & Johnson Services Inc. Major Business
2.12.3 Johnson & Johnson Services Inc. Biologics Product and Services
2.12.4 Johnson & Johnson Services Inc. Biologics Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 Johnson & Johnson Services Inc. Recent Developments/Updates
3 Competitive Environment: Biologics by Manufacturer
3.1 Global Biologics Sales Quantity by Manufacturer (2019-2024)
3.2 Global Biologics Revenue by Manufacturer (2019-2024)
3.3 Global Biologics Average Price by Manufacturer (2019-2024)
3.4 麻豆原创 Share Analysis (2023)
3.4.1 Producer Shipments of Biologics by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2023
3.4.2 Top 3 Biologics Manufacturer 麻豆原创 Share in 2023
3.4.2 Top 6 Biologics Manufacturer 麻豆原创 Share in 2023
3.5 Biologics 麻豆原创: Overall Company Footprint Analysis
3.5.1 Biologics 麻豆原创: Region Footprint
3.5.2 Biologics 麻豆原创: Company Product Type Footprint
3.5.3 Biologics 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Biologics 麻豆原创 Size by Region
4.1.1 Global Biologics Sales Quantity by Region (2019-2030)
4.1.2 Global Biologics Consumption Value by Region (2019-2030)
4.1.3 Global Biologics Average Price by Region (2019-2030)
4.2 North America Biologics Consumption Value (2019-2030)
4.3 Europe Biologics Consumption Value (2019-2030)
4.4 Asia-Pacific Biologics Consumption Value (2019-2030)
4.5 South America Biologics Consumption Value (2019-2030)
4.6 Middle East and Africa Biologics Consumption Value (2019-2030)
5 麻豆原创 Segment by Type
5.1 Global Biologics Sales Quantity by Type (2019-2030)
5.2 Global Biologics Consumption Value by Type (2019-2030)
5.3 Global Biologics Average Price by Type (2019-2030)
6 麻豆原创 Segment by Application
6.1 Global Biologics Sales Quantity by Application (2019-2030)
6.2 Global Biologics Consumption Value by Application (2019-2030)
6.3 Global Biologics Average Price by Application (2019-2030)
7 North America
7.1 North America Biologics Sales Quantity by Type (2019-2030)
7.2 North America Biologics Sales Quantity by Application (2019-2030)
7.3 North America Biologics 麻豆原创 Size by Country
7.3.1 North America Biologics Sales Quantity by Country (2019-2030)
7.3.2 North America Biologics Consumption Value by Country (2019-2030)
7.3.3 United States 麻豆原创 Size and Forecast (2019-2030)
7.3.4 Canada 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Mexico 麻豆原创 Size and Forecast (2019-2030)
8 Europe
8.1 Europe Biologics Sales Quantity by Type (2019-2030)
8.2 Europe Biologics Sales Quantity by Application (2019-2030)
8.3 Europe Biologics 麻豆原创 Size by Country
8.3.1 Europe Biologics Sales Quantity by Country (2019-2030)
8.3.2 Europe Biologics Consumption Value by Country (2019-2030)
8.3.3 Germany 麻豆原创 Size and Forecast (2019-2030)
8.3.4 France 麻豆原创 Size and Forecast (2019-2030)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Russia 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Italy 麻豆原创 Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Biologics Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Biologics Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Biologics 麻豆原创 Size by Region
9.3.1 Asia-Pacific Biologics Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Biologics Consumption Value by Region (2019-2030)
9.3.3 China 麻豆原创 Size and Forecast (2019-2030)
9.3.4 Japan 麻豆原创 Size and Forecast (2019-2030)
9.3.5 Korea 麻豆原创 Size and Forecast (2019-2030)
9.3.6 India 麻豆原创 Size and Forecast (2019-2030)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2019-2030)
9.3.8 Australia 麻豆原创 Size and Forecast (2019-2030)
10 South America
10.1 South America Biologics Sales Quantity by Type (2019-2030)
10.2 South America Biologics Sales Quantity by Application (2019-2030)
10.3 South America Biologics 麻豆原创 Size by Country
10.3.1 South America Biologics Sales Quantity by Country (2019-2030)
10.3.2 South America Biologics Consumption Value by Country (2019-2030)
10.3.3 Brazil 麻豆原创 Size and Forecast (2019-2030)
10.3.4 Argentina 麻豆原创 Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Biologics Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Biologics Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Biologics 麻豆原创 Size by Country
11.3.1 Middle East & Africa Biologics Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Biologics Consumption Value by Country (2019-2030)
11.3.3 Turkey 麻豆原创 Size and Forecast (2019-2030)
11.3.4 Egypt 麻豆原创 Size and Forecast (2019-2030)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2019-2030)
11.3.6 South Africa 麻豆原创 Size and Forecast (2019-2030)
12 麻豆原创 Dynamics
12.1 Biologics 麻豆原创 Drivers
12.2 Biologics 麻豆原创 Restraints
12.3 Biologics Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Biologics and Key Manufacturers
13.2 Manufacturing Costs Percentage of Biologics
13.3 Biologics Production Process
13.4 Biologics Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Biologics Typical Distributors
14.3 Biologics Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Eli Lilly & Company
Samsung Biologics
F Hoffman La Roche
Celltrion
Addgene
Amgen
Abbvie Inc.
Sanofi
Pfizer Inc.
Merck & Co. Inc.
Novo Nordisk A/S
Johnson & Johnson Services Inc.
听
听
*If Applicable.
